The Fredric G. Levin Lung Cancer Symposium
- Continuing Education
Experience an inspiring, community-driven symposium that unites leading medical professionals to advance lung cancer care through cutting-edge insights and evolving treatment strategies. Deepen your expertise as you explore guideline-aligned management, emerging therapies, and the expanding role of immunotherapy in improving patient outcomes.
- Live Online or In Person
Participants may attend either virtually or in person.
Institute for Human and Machine Cognition: 40 S Alcaniz Street Pensacola, FL 32502
On This Page
Overview
Join us for an exclusive medical gathering at the prestigious BWH/HMS Lung Cancer Symposium in beautiful Pensacola, Florida. This annual event unites medical professionals in a shared mission to advance knowledge and expertise in the ever-evolving field of Lung Care. This year, we're embracing the theme of "community" to connect, inspire, and broaden our horizons while staying firmly rooted in our core focus – Lung Care. Our dynamic agenda encompasses a diverse range of topics to empower you with cutting-edge insights. Discover how the dynamics of lung cancer treatment are evolving as our understanding of this unique disease deepens. Despite established guidelines, variability in patient management remains a challenge. Learn how to align with the National Comprehensive Cancer Network's (NCCN) guidelines, and stay updated on staging, treatment, and indications for neoadjuvant and adjuvant therapy. Uncover the pivotal role of immunotherapy in treating lung cancer patients. Our expert speakers will deliver engaging, topical lectures to broaden your knowledge, and open new avenues of treatment.
Agenda Highlights:
- Surgical Innovation: Unveiling the latest techniques and breakthroughs in lung cancer surgery.
- Lung Cancer Diagnosis and Screening: Exploring innovative methods for early detection.
- Resources for Lung Cancer Screening: Equipping you with the essential tools for effective screening.
- Lung Cancer Screening Programs: A deep dive into program development and best practices.
- The Importance of Multidisciplinary Collaboration: Fostering teamwork for comprehensive patient care.
- Challenges in Coordinating Multidisciplinary Care: Navigating the complexities of collaboration.
- Clinical Pathways and Collaboration: Streamlining patient journeys for optimal outcomes.
- Palliative Care: Enhancing the quality of life for lung cancer patients.
- Medical Risk and Error: Strategies for minimizing risk and maximizing patient safety.
Learning Objectives
- Review the guidelines established by the Fleischner Society and American College of Chest Physicians regarding the evaluation and management of pulmonary nodules.
- Identify the spectrum of radiologic appearance of pulmonary nodules and the range of differential diagnoses that may guide the choice of imaging.
- Discuss the spectrum of radiologic appearance of pulmonary nodules and the range of differential diagnoses that may guide the choice of imaging.
- Analyze the current role of strategies for lung cancer diagnosis and staging.
- Evaluate the advantages and limitations of limited resection for early-stage lung Analyze the technical challenges and results of extended pulmonary resection.
- Assess the current role of stereotactic body radiotherapy (SBRT) in the management of early stage non–small cell lung cancer.
- Demonstrate the use of state-of-the-art tools to diagnose and stage lung cancer.
- Demonstrate the use of new treatment technologies.
- Review new research related to pulmonary nodules and lung cancer.
Developed and Offered By:
Continuing Education courses are developed by faculty from Harvard Medical School's teaching hospitals and accredited by Harvard Medical School. This course is offered by Brigham and Women's Hospital.
Participant Types
Physician Assistants, Nurse Practitioners, Nurses, Primary Care Physicians, and Specialty Physicians
Schedule
All agenda sessions are in Eastern Time.
Friday, March 27, 2026
Welcome Remarks
8:25-8:30 am
The Ground Glass Opacity
8:30-8:45 am
The Part-Solid Lung Nodule
8:45-9:00 am
The Solid Lung Nodule
9:00-9:15 am
Panel Session
9:15-9:30 am
Break
9:30-9:45 am
Early-Stage Disease I
9:45-10:00 am
Early-Stage Disease II
10:00-10:15 am
Early-Stage Disease III
10:15-10:30 am
Alternative Treatment Options
10:30-10:45 am
Panel Session
10:45-11:00 am
Break
11:00-11:15 am
Locally Advanced Disease in the Surgical Patient I
11:15-11:30 am
Locally Advanced Disease in the Surgical Patient II
11:30-11:45 am
Locally Advanced Disease in the Surgical Patient III
11:45 am-12:00 pm
Panel Session
12:00-12:15 pm
Break for Lunch
12:15-1:15 pm
Overview Immunotherapy & Target Treatment Strategies
1:15-1:30 pm
Oligometastic Disease
1:30-1:45 pm
Management of Pleural Effusion
1:45-2:00 pm
Pericardial Effusion
2:00-2:15 pm
Airway Disease
2:15-2:30 pm
Panel Session
2:30-2:45 pm
Break
2:45-3:00 pm
Mesothelioma
3:00-3:20 pm
We Will Take Your Thoracic Cases
3:20-3:35 pm
Panel Session
3:35-3:50 pm
Day 1 Closing Remarks
3:50-4:05 pm
Saturday, March 28, 2026
Welcome Remarks
8:25-8:30 am
Isolated Lymphadenopathy
8:30-8:45 am
Lung Infections and Abscess
8:45-9:00 am
Empyema
9:00-9:15 am
Pneumomediastinum
9:15-9:30 am
Esophageal Perforations
9:30-9:45 am
Thoracic Trauma
9:45-10:00 am
Panel Session
10:00-10:15 am
Break
10:15-10:30 am
Spontaneous Pneumothorax
10:30-10:45 am
Interstitial Lung Disease
10:45-11:00 am
Paraesophageal/ Hiatal Hernia Repair
11:00-11:15 am
Chest Wall
11:15-11:30 am
Approaches to Mediastinal Masses
11:30-11:45 am
Panel Session
11:45 am-12:00 pm
Day 2 Closing Remarks
12:00-12:05 pm
Faculty
Harvard Medical School Continuing Education attracts the best and brightest faculty from all around the world. As a student in this course, you’ll have access to outstanding course directors and faculty.
Course Directors
Matthew Pommerening
MD, MS | Course Director
Raphael Bueno, MD
Kaley Collier, BS
Carol Daunais-Kurpis, BA
Rian Hasson, MD, MPH
Michael Jaklitsch, MD
Meaghan Kudla, BSN
Matthew Rochefort, MD
Jon Wee, MD
Mark Hammer, MD
Justin Gainor, MD
Complete Your Registration
Started a registration? Log in to enroll today.
Request Information
Interested in learning more about this program? Sign up for details.
Course Fees
Fee Disclaimer
You may register through our secure online environment and will receive an email confirmation upon receipt of your payment. Virtual tuition includes electronic syllabus.
At the end of the registration process, a $10 non-refundable processing fee will be added to your registration.
| Role | Course Fee |
|---|---|
| Physician (MD/DO) | $200.00 |
| Nurse (RN/APRN) | $200.00 |
| PA | $200.00 |
| Psychologist | $200.00 |
| Resident/Fellow | $150.00 |
| Social Worker | $200.00 |
| Allied Health Professional / Other | $150.00 |
Accreditation
The Harvard Medical School designates this live activity for a maximum of 7.75 AMA PRA Category 1 Credit(s)™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
Harvard Medical School designates this live activity for a maximum of 7.75 ANCC contact hours.
The National Commission on Certification of Physician Assistants (NCCPA) states that 7.75 AMA PRA Category 1 Credits™ are acceptable for continuing medical education requirements for recertification. We would also suggest that learners check with their state licensing board to ensure they accept reciprocity with 7.75 AMA PRA Category 1 Credit™ for re-licensure.
The American Medical Association (AMA) has an agreement of mutual recognition of continuing medical education (CME) credit with the European Union of Medical Specialties (UEMS). Additional information regarding this agreement may be found on the European Union of Medical Specialties website.
The Royal College of Physicians and Surgeons of Canada recognizes conferences and workshops held outside of Canada that are developed by a university, academy, hospital, specialty society or college as accredited group learning activities.